We are live on ! Find out more
SILO icon

Silo Pharma

13 hedge funds and large institutions have $285K invested in Silo Pharma in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more capital inflows, than outflows

Capital inflows: $261K | Capital outflows: $107K

1.29% more ownership

Funds ownership: 4.26% → 5.55% (+1.3%)

19% less funds holding

Funds holding: 16 → 13 (-3)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
13
Holders Change
-3
Holders Change %
-18.75%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SILO Hedge Fund Activity: Q1 2025 in Review

13 of the 7,492 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q1 2025, worth a combined $285K — up 69% from $168K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SILO and 4 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was AdvisorShares Investments, opening a new position worth an estimated $185K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $33.4K sold.

  • 13 institutional investors held Silo Pharma (SILO) as of Q1 2025, down from 16 in Q4 2024.
  • Funds reported $285K of Silo Pharma stock for Q1 2025, up 69% quarter-over-quarter.
  • 4 funds opened new Silo Pharma positions in Q1 2025 and 7 closed out, a net change of -3 holders.
  • The largest Silo Pharma buyer in Q1 2025 was AdvisorShares Investments, an estimated $185K added.
  • The largest Silo Pharma seller in Q1 2025 was Renaissance Technologies, an estimated $33.4K sold.

Based on aggregated 13F filings for Q1 2025.